Lewis R. Silverman, MD: An Overview of Myelodysplastic Syndrome and Personalized Therapies
Lewis R. Silverman, MD, is one of the foremost researchers into myelodysplastic syndrome (MDS), and was the Principal Investigator for the clinical trials which led to FDA approval of azacitidine, the first drug approved for this disease. In this Grand Rounds presentation, Dr. Silverman discusses the causes, gene mutations, progression, and treatments of MDS—as well as the most recent developments in research.
Director, Translational Research Center for Myelodysplastic Syndrome, The Tisch Cancer Institute
Associate Professor of Medicine (Hematology and Medical Oncology), and Oncological Sciences